IDEAYA Biosciences, Inc. Common Stock IDYA

$25.56 -2.33% at last close

Analyst Consensus

Consensus Rating
Buy (11 Buy · 1 Hold · 0 Sell)
Average Price Target
$49.55
Implied Upside
+93.8%
Price Target Range
$35.00 – $66.00
Analysts (12 mo)
12

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-11-17
RBC CapitalLeonid Timashev
Reiterates Outperform $45
2026-11-10
MizuhoGraig Suvannavejh
Maintains Outperform $44 → $39
2026-11-05
CitigroupYigal Nochomovitz
Maintains Buy $65 → $66
2026-11-04
RBC CapitalLeonid Timashev
Maintains Outperform $48 → $45
2026-11-04
Truist SecuritiesGregory Renza
Reiterates Buy $59 → $57
2026-11-04
GuggenheimPaul Jeng
Maintains Buy $57 → $52
2026-11-04
WedbushRobert Driscoll
Maintains Outperform $60 → $63
2026-10-16
William BlairAlethia Young
Initiates coverage on Outperform —
2026-10-14
StifelLaura Prendergast
Initiates coverage on Buy $48
2026-09-09
GuggenheimPaul Jeng
Maintains Buy $54 → $57
2026-09-01
CitizensSilvan Turkcan
Reiterates Market outperform $42
2026-08-05
Truist SecuritiesGregory Renza
Maintains Buy $63 → $59
2026-08-05
WedbushRobert Driscoll
Maintains Outperform $58 → $60
2026-07-07
RBC CapitalLeonid Timashev
Maintains Outperform $53 → $48
2026-07-07
Truist SecuritiesGregory Renza
Maintains Buy $65 → $63
2026-06-12
WedbushRobert Driscoll
Reiterates Outperform $58
2026-06-02
WedbushRobert Driscoll
Reiterates Outperform $58
2026-05-07
MizuhoGraig Suvannavejh
Maintains Outperform $52 → $50
2026-04-14
Goldman SachsCorinne Jenkins
Maintains Neutral $31 → $35
2026-04-14
Wells FargoEva Fortea Verdejo
Maintains Overweight $44 → $48
2026-04-14
RBC CapitalLeonid Timashev
Maintains Outperform $49 → $53
2026-04-14
WedbushRobert Driscoll
Maintains Outperform $52 → $58
2026-04-14
GuggenheimPaul Jeng
Maintains Buy $50 → $54
2026-03-31
WedbushRobert Driscoll
Reiterates Outperform $52
2026-02-19
CitigroupYigal Nochomovitz
Maintains Buy $64 → $65
2026-02-18
RBC CapitalLeonid Timashev
Reiterates Outperform $49
2026-02-18
GuggenheimPaul Jeng
Reiterates Buy $50
2026-02-18
WedbushRobert Driscoll
Maintains Outperform $49 → $52
2026-01-21
RBC CapitalLeonid Timashev
Maintains Outperform $41 → $45
2026-01-07
UBSMichael Yee
Assumes Buy $50

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$25.56
Market Cap
$2.47 billion
52-Week Range
$25.46 – $42.68
Average Volume
1.08 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.